Medicare

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug…

4 weeks ago

Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ™ in Leptomeningeal Metastases

HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision…

4 weeks ago

New Colorado Study Confirms Health Information Exchange Lowers Emergency Department and Inpatient Utilization

Positive impact measured across patients with all insurance types, particularly MedicaidDENVER--(BUSINESS WIRE)--A new peer-reviewed study published in the Journal of…

1 month ago

Appian AI Transforms Clinical Workflows for Global Public Health Agencies

Appian and Ignyte Group Win Global HL7 AI Challenge for ethical, proactive healthcare innovation. MCLEAN, Va., Nov. 20, 2025 /PRNewswire/…

1 month ago

CVS Pharmacy® introduces Joyward™, a new brand designed to bring the joy of every moment to life

WOONSOCKET, R.I., Nov. 20, 2025 /PRNewswire/ -- CVS Pharmacy® today announced the launch of Joyward™, a new line of decor,…

1 month ago

Oracle Health Secures TEFCA QHIN Designation, Further Strengthening Interoperability Leadership

Oracle Health customers can easily sign up today to participate and capture data from across the healthcare ecosystem to create…

1 month ago

Johns Hopkins Health Plans Welcomes Inova Health To Medicare Advantage Network

Relationship Enhances Care Access as Advantage MD Expands Virginia Service AreaHANOVER, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Effective Jan.…

1 month ago

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”),…

1 month ago

SafeRide Health Ranks 84th Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™

One of the nation's leading NEMT companies, SafeRide attributes 1,116% revenue growth to member-centric initiatives that reduce confusion, improve coordination,…

1 month ago

Medicure Reports Financial Results for Quarter Ended September 30, 2025

WINNIPEG, MB / ACCESS Newswire / November 19, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused…

1 month ago